Cai-Jin Lin

Molecular classification of hormone receptor-positive HER2-negative breast cancer

Wei Huang, Yizhou Jiang, D. Ma, 2023, Nature Genetics.

Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer.

Jin-xiu Shi, Hong Ling, Bo-yue Han, 2024, Cancer letters.

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities

D. Ma, Yuchen Pei, Jin-xiu Shi, 2023, Cell discovery.